Product/Service

Early Phase

Source: ICON

Translational Medicine

ICON Development Solutions specialises in the strategy and delivery of early-phase clinical development services to enable informed, timely decision making for our clients.

Request Information

ICON Development Solutions specialises in the strategy and delivery of early-phase clinical development services to enable informed, timely decision making for our clients.

With global clinical pharmacology and bioanalytical presence, ICON offers industry-leading capabilities in early-phase clinical research, bioanalytical/immunoassay, biomarkers, PK, PD, modeling & simulation and the full range of support services.

Key services include:

  • Product development consulting
  • Protocol design
  • Regulatory affairs strategy / submission
  • Phase I studies including:
    • Food effect studies
    • Dosage Regimen assessments
    • Diabetic Clamp studies
    • QTc studies
    • First in man, dose escalation, PK/PD
    • Multiple dose studies
    • Drug interaction studies
    • Bioavailability, bioequivilence
    • Phase I patient studies
    • Special population studies
  • Phase II studies including:
    • Patient studies
    • Special population studies
    • Proof of concept studies
  • PK/PD Analysis
  • Modelling and simulation

 

Need More Information? Just Ask.

Click the button below to directly contact the supplier. Use it to:

  • Ask a question.
  • Request more detailed information or literature.
  • Discuss your current project/application.
  • Request a quote.
  • Locate a distributor in your area.
  • Schedule a demo.
Request Information